Joshua Englert

Title: Innovations by Joshua Englert in Lung Inflammation Therapy

Introduction

Joshua Englert is an innovative inventor based in Powell, OH (US). He has made significant contributions to the field of lung inflammation therapy through his research and development of novel therapeutic solutions. His work focuses on utilizing extracellular vesicles (EVs) to deliver anti-inflammatory agents directly to the lungs.

Latest Patents

Englert holds a patent for "Nanocarriers for lung inflammation therapy." This patent discloses lung-targeted extracellular vesicles loaded with an anti-inflammatory cargo. The invention includes compositions, systems, and methods for creating these EVs, which can contain a lung-targeted ligand, such as a fusion protein with a lung-targeting moiety. The patent also describes an EV-producing cell engineered to produce these EVs and outlines a method for their production by culturing the EV-producing cells under suitable conditions. He has 1 patent to his name.

Career Highlights

Joshua Englert is associated with the Ohio State Innovation Foundation, where he continues to advance his research in the field of lung therapies. His innovative approach to using EVs for targeted delivery of anti-inflammatory agents showcases his commitment to improving therapeutic outcomes for patients suffering from lung inflammation.

Collaborations

Englert collaborates with talented individuals such as Natalia Higuita-Castro and Daniel Gallego-Perez. Their combined expertise enhances the research and development efforts at the Ohio State Innovation Foundation.

Conclusion

Joshua Englert's work in developing nanocarriers for lung inflammation therapy represents a significant advancement in medical technology. His innovative approach and dedication to research are paving the way for new therapeutic options in the treatment of lung-related conditions.